Dunlop A. Sinclair sold Apellis Pharmaceuticals ($APLS) shares on the open market three times in the last year, totaling $2.15 million. His most recent sale occurred on October 10, 2025. These sales rank 3,349th among 11,678 insiders in our database, where the average is $8.6 million across 6.4 transactions. Sinclair made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Common Stock | 7961 | $0.00 | 161,567.0000 | 130,067,000 | 5.18% | 0.01% |
| Jan. 1, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Oct. 10, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | J | Common Stock | 3837 | $0.00 | 153,606.0000 | 130,067,000 | 2.44% | 0.00% |
| Oct. 10, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 31092 | $23.72 | 157,443.0000 | 130,067,000 | 16.49% | 0.02% |
| June 24, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | J | Common Stock | 4787 | $0.00 | 153,606.0000 | 123,905,000 | 3.02% | 0.00% |
| Sept. 30, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 31092 | $22.58 | 192,372.0000 | 123,905,000 | 13.91% | 0.03% |
| Sept. 30, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | J | Common Stock | 3837 | $0.00 | 188,535.0000 | 123,905,000 | 1.99% | 0.00% |
| Sept. 19, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 31092 | $22.95 | 227,301.0000 | 123,905,000 | 12.03% | 0.03% |
| Sept. 19, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | J | Common Stock | 3837 | $0.00 | 223,464.0000 | 123,905,000 | 1.69% | 0.00% |
| Jan. 1, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Common Stock | 6267 | $0.00 | 258,393.0000 | 123,905,000 | 2.49% | 0.01% |
| Jan. 1, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Sept. 23, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 4600 | $0.00 | 0.0000 | 118,678,000 | 100.00% | 0.00% |
| Sept. 23, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Common Stock | 4600 | $13.19 | 252,126.0000 | 118,678,000 | 1.86% | 0.00% |
| Sept. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 7524 | $36.79 | 247,526.0000 | 118,678,000 | 2.95% | 0.01% |
| Sept. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 29476 | $36.09 | 255,050.0000 | 118,678,000 | 10.36% | 0.02% |
| June 28, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 900 | $0.00 | 4,600.0000 | 118,678,000 | 16.36% | 0.00% |
| June 28, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Common Stock | 900 | $13.19 | 303,271.0000 | 118,678,000 | 0.30% | 0.00% |
| June 21, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 1695 | $39.63 | 302,371.0000 | 118,678,000 | 0.56% | 0.00% |
| June 21, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 35305 | $39.22 | 304,066.0000 | 118,678,000 | 10.40% | 0.03% |
| April 12, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Common Stock | 1500 | $13.19 | 339,371.0000 | 118,678,000 | 0.44% | 0.00% |
| April 12, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 1500 | $0.00 | 5,500.0000 | 118,678,000 | 21.43% | 0.00% |
| March 19, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 18681 | $57.18 | 337,871.0000 | 118,678,000 | 5.24% | 0.02% |
| Jan. 1, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Common Stock | 3341 | $0.00 | 356,552.0000 | 118,678,000 | 0.95% | 0.00% |
| Jan. 1, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Dec. 14, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Common Stock | 6274 | $13.19 | 353,211.0000 | 106,114,000 | 1.81% | 0.01% |
| Dec. 14, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 6274 | $0.00 | 7,000.0000 | 106,114,000 | 47.27% | 0.01% |
| Dec. 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Not found | S | Common Stock | 24000 | $61.14 | 346,937.0000 | 106,114,000 | 6.47% | 0.02% |
| Oct. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | S | Common Stock | 24000 | $49.00 | 379,831.0000 | 106,114,000 | 5.94% | 0.02% |
| Nov. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | S | Common Stock | 8894 | $49.99 | 370,937.0000 | 106,114,000 | 2.34% | 0.01% |
| April 3, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $74.05 | 403,831.0000 | 106,114,000 | 0.12% | 0.00% |
| March 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $65.33 | 404,331.0000 | 106,114,000 | 0.12% | 0.00% |
| Feb. 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $52.61 | 404,831.0000 | 106,114,000 | 0.12% | 0.00% |
| Jan. 3, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $50.70 | 405,331.0000 | 106,114,000 | 0.12% | 0.00% |
| Jan. 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Common Stock | 3867 | $0.00 | 405,831.0000 | 106,114,000 | 0.96% | 0.00% |
| Jan. 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |